- Home
- RPID vs RDIB Comparison
RPID vs RDIB Comparison
Compare RPID & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- RDIB
- Stock Information
- Founded
- RPID 2006
- RDIB 1937
- Country
- RPID United States
- RDIB United States
- Employees
- RPID N/A
- RDIB N/A
- Industry
- RPID Medical Specialities
- RDIB Movies/Entertainment
- Sector
- RPID Health Care
- RDIB Consumer Discretionary
- Exchange
- RPID Nasdaq
- RDIB Nasdaq
- Market Cap
- RPID 145.1M
- RDIB 140.2M
- IPO Year
- RPID 2021
- RDIB N/A
- Fundamental
- Price
- RPID $3.33
- RDIB $10.55
- Analyst Decision
- RPID Buy
- RDIB
- Analyst Count
- RPID 1
- RDIB 0
- Target Price
- RPID $8.00
- RDIB N/A
- AVG Volume (30 Days)
- RPID 163.7K
- RDIB 6.0K
- Earning Date
- RPID 05-09-2025
- RDIB 06-06-2025
- Dividend Yield
- RPID N/A
- RDIB N/A
- EPS Growth
- RPID N/A
- RDIB N/A
- EPS
- RPID N/A
- RDIB N/A
- Revenue
- RPID $29,645,000.00
- RDIB $205,644,000.00
- Revenue This Year
- RPID $18.54
- RDIB $9.74
- Revenue Next Year
- RPID $20.55
- RDIB $6.39
- P/E Ratio
- RPID N/A
- RDIB N/A
- Revenue Growth
- RPID 28.36
- RDIB N/A
- 52 Week Low
- RPID $0.58
- RDIB $5.78
- 52 Week High
- RPID $4.04
- RDIB $21.34
- Technical
- Relative Strength Index (RSI)
- RPID 61.61
- RDIB 51.21
- Support Level
- RPID $3.15
- RDIB $9.30
- Resistance Level
- RPID $3.84
- RDIB $11.35
- Average True Range (ATR)
- RPID 0.27
- RDIB 1.09
- MACD
- RPID 0.02
- RDIB -0.14
- Stochastic Oscillator
- RPID 50.96
- RDIB 27.23
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial, and live theater assets.